Introduction

Conventional subcutaneous xenograft models provide accessible and reproducible systems for studying tumor growth, but they lack the anatomical and physiological context of the original tumor site. To address this, advanced xenograft methodologies—orthotopic, metastatic, and disseminated models—have been developed. These approaches more accurately reflect human disease progression, including tumor–microenvironment interactions, metastatic spread, and therapeutic response heterogeneity. They are increasingly vital for testing novel therapeutics in settings that recapitulate the complexity of clinical oncology.

Orthotopic Xenograft Models

Orthotopic models involve implanting tumor cells or patient-derived tumor fragments directly into the tissue of origin (e.g., breast tumors into mammary fat pads, glioblastoma cells intracranially).

• Advantages: Tumors grow in their natural microenvironment, preserving local signaling pathways, angiogenesis patterns, and interactions with adjacent tissue.
• Applications: Orthotopic models are particularly valuable for evaluating invasive behavior, tumor–stroma crosstalk, and site-specific therapeutic delivery. For example, orthotopic pancreatic xenografts mimic the fibrotic stroma and hypovascularity observed in patients.
• Limitations: Surgical complexity and challenges in tumor monitoring (often requiring imaging modalities such as MRI or bioluminescence).

Metastatic Xenograft Models

Metastatic models replicate the process of tumor dissemination to distant organs, providing critical insights into late-stage disease progression. Approaches include intravenous or intracardiac injection of tumor cells, as well as spontaneous metastasis from orthotopic tumors.

• Advantages: Capture multistep metastatic cascades including intravasation, circulation, extravasation, and colonization of distant sites.
• Applications: Widely used to study bone metastasis in breast and prostate cancer, liver metastasis in colorectal cancer, and lung colonization in melanoma. They are essential for developing anti-metastatic therapies and evaluating drug penetration into metastatic niches.
• Limitations: Variability in metastatic efficiency and difficulty in controlling dissemination patterns across animals.

Disseminated Xenograft Models

Disseminated models are primarily applied to hematological malignancies such as leukemia, lymphoma, and multiple myeloma. Tumor cells are injected intravenously, leading to systemic disease that closely parallels human pathophysiology.

• Advantages: Accurately replicate bone marrow infiltration, splenic involvement, and circulating tumor cells.
• Applications: Widely used for evaluating chemotherapy, targeted agents, and immunotherapies in blood cancers. They are also instrumental for monitoring minimal residual disease and relapse patterns.
• Limitations: Require sensitive detection methods such as flow cytometry or bioluminescence to track disease burden.

Comparative Insights

• Orthotopic models excel in recapitulating primary tumor biology within the correct tissue context.
• Metastatic models are indispensable for capturing late-stage disease and therapeutic challenges associated with secondary organ colonization.
• Disseminated models uniquely replicate hematologic cancer dynamics, enabling translational drug testing in systemic malignancies.
  Together, these advanced xenograft systems complement subcutaneous models, creating a more comprehensive preclinical toolkit.

Future Perspectives

The next generation of murine xenograft methodologies will increasingly integrate imaging technologies, CRISPR-based lineage tracing, and multi-omics profiling to dissect tumor progression with higher resolution. Humanized versions of these models—incorporating human immune systems and stromal components—will further expand their utility for immuno-oncology and personalized medicine. As oncology research continues to prioritize translational relevance, advanced xenograft methodologies will remain indispensable for bridging preclinical insights with clinical application.